Trump says he’s ‘not giving up’ on building a wall
President Donald Trump pledged anew to build a wall between the U.S. and Mexico, saying he’s ready to make a deal with the Democrats when they provide funding for border security.
All Posts in "Markets"
U.S. oil ekes out a gain as futures close out declines for month, quarter and year
Natural-gas futures decline by the most in a month on a percentage basis since March of 2003
Which markets are closed — and when — on New Year’s Eve and New Year’s Day?
Nearly all major markets are closed on New Year’s Day
PG&E could, in theory, face murder charges in California wildfires
PG&E could, in theory, face murder charges in California wildfires
U.S. presses China for details on deal to resolve trade tensions
U.S. presses China for details on deal to resolve trade tensions
The euro is set to celebrate its 20th birthday — here’s a look back at its tumultuous history
From a noble idea to ‘whatever it takes’
U.S. stock futures buoyed by trade-deal hopes ahead of last session for dismal 2018
2018 shaping up as worst year for major indexes since 2008
Tesla wins plaudits for slotting Larry Ellison onto its board, but its problems won’t magically vanish
Critics are concerned that the Oracle co-founder’s friendship with Elon Musk and his large stake in Tesla may create a conflict of interest
Airlines say goodbye to the 747 amid a transformation in international travel
Smaller, ultra-efficient long-range airliners are overtaking the once-celebrated aircraft.
Here’s why stock-market bulls are banking on January to steady the ship
More insight into earnings, trade talks and the Federal Reserve could help set up the next market rebound
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Tweaking one setting on mechanical ventilators may help protect patients from lung injury
Eli Lilly seeks new angle on high-value target, tapping Oblique for antibody discovery push
While FDA mulls Zevra’s rare disease med, Rafael merges with Cyclo to push their rival candidate
Despite mixed market, a venture capital revival could be coming in Europe: PitchBook
Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain
Ex-GSK CEO takes up board post at aging and obesity biotech BioAge
After $213M round, gene editing biotech Tome shrinks operations as investor sentiment worsens
Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Roche ramps up lab testing capacity for mpox worldwide following WHO declaration